Junshang Ge

2.3k total citations · 1 hit paper
16 papers, 1.4k citations indexed

About

Junshang Ge is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Junshang Ge has authored 16 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Immunology. Recurrent topics in Junshang Ge's work include Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers) and MicroRNA in disease regulation (4 papers). Junshang Ge is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers) and MicroRNA in disease regulation (4 papers). Junshang Ge collaborates with scholars based in China, Saudi Arabia and United States. Junshang Ge's co-authors include Wei Xiong, Guiyuan Li, Zhaoyang Zeng, Can Guo, Xianjie Jiang, Jie Wang, Ming Zhou, Bo Xiang, Yong Li and Xiaoling Li and has published in prestigious journals such as Cancer Research, Oncogene and Analytica Chimica Acta.

In The Last Decade

Junshang Ge

13 papers receiving 1.4k citations

Hit Papers

Role of the tumor microenvironment in PD-L1/PD-1-mediated... 2019 2026 2021 2023 2019 250 500 750 1000

Peers

Junshang Ge
Junshang Ge
Citations per year, relative to Junshang Ge Junshang Ge (= 1×) peers Marion Thibaudin

Countries citing papers authored by Junshang Ge

Since Specialization
Citations

This map shows the geographic impact of Junshang Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junshang Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junshang Ge more than expected).

Fields of papers citing papers by Junshang Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junshang Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junshang Ge. The network helps show where Junshang Ge may publish in the future.

Co-authorship network of co-authors of Junshang Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Junshang Ge. A scholar is included among the top collaborators of Junshang Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junshang Ge. Junshang Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wang, Qian, Yuhang Liu, Shanshan Zhang, et al.. (2025). Arecoline upregulates CD155 expression to facilitate immune evasion in oral squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 13(12). e012982–e012982.
3.
Wang, Jie, Rong Wang, Meifeng Wang, et al.. (2025). Cutting‐Edge Therapy and Immune Escape Mechanisms in EBV‐Associated Tumors. Medicinal Research Reviews. 45(4). 1184–1210. 1 indexed citations
4.
Yang, Yujie, Yian Wang, Hongke Qu, et al.. (2025). CircCDYL promotes glycolysis to drive the progression of nasopharyngeal carcinoma. Journal of Advanced Research.
5.
Ge, Junshang, Ying Liu, Pan Chen, et al.. (2024). FOXA1 enhances antitumor immunity via repressing interferon-induced PD-L1 expression in nasopharyngeal carcinoma. Journal for ImmunoTherapy of Cancer. 12(11). e010091–e010091. 3 indexed citations
6.
Zhi, Yuan, Shanshan Zhang, Junshang Ge, et al.. (2024). Spatial Transcriptomic and Metabolomic Landscapes of Oral Submucous Fibrosis‐Derived Oral Squamous Cell Carcinoma and its Tumor Microenvironment. Advanced Science. 11(12). e2306515–e2306515. 34 indexed citations
7.
Huang, Mao, Yixuan Liu, Qijia Yan, et al.. (2024). NK cells as powerful therapeutic tool in cancer immunotherapy. Cellular Oncology. 47(3). 733–757. 4 indexed citations
8.
Wang, Yian, Xianjie Jiang, Junshang Ge, et al.. (2024). Nanomaterials Boost CAR‐T Therapy for Solid Tumors. Advanced Healthcare Materials. 13(20). e2304615–e2304615. 14 indexed citations
9.
Zeng, Hong-Li, et al.. (2024). Research progress on the role and mechanism of circular RNA in drug resistance of head and neck squamous cell carcinoma. Cancer Drug Resistance. 7. 31–31. 2 indexed citations
10.
Ge, Junshang, Jie Wang, Fang Xiong, et al.. (2021). Epstein–Barr Virus–Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1. Cancer Research. 81(19). 5074–5088. 113 indexed citations
11.
Zhu, Kunjie, Junshang Ge, Yi He, et al.. (2021). Bioinformatics Analysis of the Signaling Pathways and Genes of Gossypol Induce Death of Nasopharyngeal Carcinoma Cells. DNA and Cell Biology. 40(8). 1052–1063. 3 indexed citations
12.
Qu, Hongke, Mingjian Chen, Junshang Ge, et al.. (2021). A fluorescence strategy for circRNA quantification in tumor cells based on T7 nuclease-assisted cycling enzymatic amplification. Analytica Chimica Acta. 1189. 339210–339210. 25 indexed citations
13.
Zhu, Kunjie, Yongzhen Mo, Jie Wang, et al.. (2020). Neutrophils: Accomplices in metastasis. Cancer Letters. 492. 11–20. 20 indexed citations
14.
Jin, Zhao, Can Guo, Fang Xiong, et al.. (2020). Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal carcinoma. Cancer Letters. 477. 131–143. 85 indexed citations
15.
Ge, Junshang, Jie Wang, Xianjie Jiang, et al.. (2019). The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer. Journal of Cancer. 11(4). 932–939. 50 indexed citations
16.
Jiang, Xianjie, Jie Wang, Xiangying Deng, et al.. (2019). Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape. Molecular Cancer. 18(1). 10–10. 1064 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026